We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




System Simultaneously Quantifies mRNA, microRNA, and DNA

By LabMedica International staff writers
Posted on 31 Aug 2011
A multiplex polymerase chain reaction (PCR) platform simultaneously detects and quantifies disparate target types, such as mRNA, miRNA, single nucleotide polymorphisms (SNPs), and DNA.

Called ICEPlex, the open platform will enable clinical labs to develop cost-effective, high impact molecular diagnostic tests easily. More...
ICEPlex is an automated high throughput, high multiplex, molecular testing system based on Scalable Target Amplification Routine (STAR) technology. A stand-alone bench-top analyzer, it is capable of running up to 96 samples (including controls) and reporting on up to 60 targets in each in less than four hrs.

Because of the high level of multiplex enabled by STAR, multiple standards and calibrants are included in each sample along with primers for the intended targets. These are employed to enable reliable and sensitive detection of targets and accurate quantitative determinations of target load.

PrimeraDx (Mansfield, MA, USA) launched the ICEPlex system, which allows users to take one slice of tissue, extract the nucleic acids, and in one well in parallel, look at mRNA expression, microRNA expression, and SNPs.

Andrew Schade, MD, PhD, senior director of Lilly Clinical Diagnostics Laboratory (Indianapolis, IN, USA) commented, “The ICEPlex system is already changing the way we approach assay development, allowing us to create innovative solutions that were previously not possible.”

Related Links:

PrimeraDx
Lilly Clinical Diagnostics Laboratory



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Modular Hemostasis Automation Solution
CN Track
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.